Ursula Kirchmayer
Overview
Explore the profile of Ursula Kirchmayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
945
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trabace L, Banzi R, Ruggieri A, Addis A, Belleudi V, Barone-Adesi F, et al.
Epidemiol Prev
. 2024 Oct;
48(4-5):295-297.
PMID: 39434639
No abstract available.
2.
Sciancalepore F, Lombardi N, Valdiserra G, Bonaso M, Cappello E, Hyeraci G, et al.
Neuroepidemiology
. 2024 Oct;
:1-14.
PMID: 39380477
Introduction: No systematic reviews were published in the last years investigating epidemiological data, involving myasthenia gravis (MG) and related myasthenic syndromes. This systematic review aimed to estimate the prevalence, incidence,...
3.
Paoletti O, Hyeraci G, Finochietti M, Celani M, Bacigalupo I, Lombardi N, et al.
Eur J Neurol
. 2024 Sep;
31(12):e16470.
PMID: 39297678
Background And Purpose: The purpose was to describe the use patterns of pharmacological and non-pharmacological therapies and investigate potential determinants of riluzole use in patients newly diagnosed with amyotrophic lateral...
4.
Bacigalupo I, Finocchietti M, Paoletti O, Bargagli A, Brunori P, Lombardi N, et al.
Epidemiol Prev
. 2024 Jul;
48(3):201-209.
PMID: 38995133
Objectives: to estimate Amyotrophic Lateral Sclerosis (ALS) incidence and prevalence in three Italian Regions (Lazio, Tuscany, and Umbria), using health administrative databases. Design: retrospective population-based study. Setting And Participants: ALS...
5.
Finocchietti M, Crescioli G, Paoletti O, Brunori P, Sciancalepore F, Tuccori M, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38893023
: In the context of a comparative study of efficacy and safety of drugs used in rare neuromuscular and neurodegenerative diseases (CAESAR-call AIFA_FV_2012-13-14), we assessed the use patterns of drugs...
6.
Servadio M, Rosa A, Addis A, Kirchmayer U, Cozzi I, Michelozzi P, et al.
BMC Public Health
. 2024 Jun;
24(1):1543.
PMID: 38849792
Background: Lung cancer is one of the most lethal cancers worldwide and patient clinical outcomes seem influenced by their socioeconomic position (SEP). Since little has been investigated on this topic...
7.
Kirchmayer U, Marino C, Feriozzi S, Massimetti C, Manzuoli M, Angelici L, et al.
BMC Nephrol
. 2024 Mar;
25(1):98.
PMID: 38493085
Background: Entering dialysis is a critical moment in patients' healthcare journey, and little is known about drug therapy around it. A study funded by the Italian Medicines Agency offered the...
8.
da Silva Machado F, Canas M, Urtasun M, Marin G, Albuquerque F, Pont L, et al.
Ther Innov Regul Sci
. 2024 Mar;
58(3):549-556.
PMID: 38436905
Background: Biosimilar medicines are defined as biological products highly similar to an already licensed biological product (RP). The market entry of biosimilars is expected to reduce the costs of biological...
9.
Crescioli G, Finocchietti M, Paoletti O, Brunori P, Sciancalepore F, Tuccori M, et al.
Front Neurol
. 2024 Jan;
14:1293626.
PMID: 38178892
Introduction: To evaluate the use of pyridostigmine in presence of contraindications, and the use of concomitant potentially contraindicated drugs in a cohort of patients affected by Myasthenia Gravis (MG) in...
10.
Giometto S, Finocchietti M, Paoletti O, Lombardi N, Celani M, Sciancalepore F, et al.
Pharmacoepidemiol Drug Saf
. 2023 Nov;
33(1):e5736.
PMID: 38014926
Purpose: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease. Riluzole may increase survival and delay the need for mechanical ventilation. The CAESAR project ('Comparative evaluation of the efficacy and...